Its two major isoforms regulated by alternative splicing of exon 30 [5], referred to as long isoform (ITSN1-L) and short isoform (ITSN1-S), displayed opposite roles in glioma progression according to our previous studies [6]. Here, ITSN1 is linked to central nervous system cancer.